Welcome. How can we help?
30 Day Trial
30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Subscribe to see current content

2014 Revenue: Biomet

(for period ended 11/30/14) $844MM, +4% (U.S. $512MM, +4%; Europe $206MM, +1%; Other International $125MM, +10%) (Without Dental, $776MM, +3%) Hips $168.0MM, +3% (U.S. flat) Knees...

2014: A Recap of Strategic Activities

To begin 2015, let’s look back at what fueled growth in 2014. Here, we present companies that have merged and emerged, products that launched, projects that received fun...

Business Development Execs Speak on M&A and Innovation

Leaders from Smith & Nephew, Medtronic and Biomet convened for a roundtable focused on acquisition and insight that provides a glimpse of current and future movement in the orthopaedic industry.

Industry Investments Stay Steady, Focus on Established Technologies

Investments in the orthopaedic companies remained stagnant in 2014, as backers focused on industries with higher margins and quicker returns.

2014: A Recap of Strategic Activities in Spine

Editor’s Note: This segment-specific article is excerpted from the full version, covering major market segments, appearing in ORTHOKNOW January 2015. To begin 2015, let’s look back...

Page Navigation